keyword
https://read.qxmd.com/read/37792028/bypass-surgery-versus-endovascular-revascularization-for-occlusive-infrainguinal-peripheral-artery-disease-a-meta-analysis-of-randomized-controlled-trials-for-the-development-of-the-italian-guidelines-for-the-treatment-of-diabetic-foot-syndrome
#21
REVIEW
Alessia Scatena, Matteo Apicella, Michele Mantuano, Francesco Liistro, Giorgio Ventoruzzo, Pasquale Petruzzi, Cesare Miranda, Luca Monge, Benedetta Ragghianti, Antonio Silverii, Isabella Ferraro, Luigi Uccioli, Cristiana Vermigli, Edoardo Mannucci, Germano Scevola, Eugenio Stabile, Mauro Gargiulo, Matteo Monami
To report a review and meta-analysis of all randomized controlled trials (RCTs) comparing bypass surgery (BS) and endovascular treatment (ET) in infrainguinal peripheral arterial disease (PAD) for several endpoints, such as major and minor amputation, major adverse limb events (MALEs), ulcer healing, time to healing, and all-cause mortality to support the development of the Italian Guidelines for the Treatment of Diabetic Foot Syndrome (DFS). A MEDLINE and EMBASE search was performed to identify RCTs, published since 1991 up to June 21, 2023, enrolling patients with lower limb ischemia due to atherosclerotic disease (Rutherford I-VI)...
January 2024: Acta Diabetologica
https://read.qxmd.com/read/37777272/negative-pressure-wound-therapy-npwt-is-superior-to-conventional-moist-dressings-in-wound-bed-preparation-for-diabetic-foot-ulcers-a-randomized-controlled-trial
#22
RANDOMIZED CONTROLLED TRIAL
Yin Wu, Gan Shen, Chao Hao
OBJECTIVES: To compare the efficacy of negative pressure wound therapy (NPWT) and alginate dressings on wound bed preparation prior to split thickness skin graft (STSG) surgery for patients with chronic diabetic foot ulcers (DFUs). METHODS: Between September 2022 and March 2023, we completed a randomized controlled trial in Nanjing First Hospital and PLA 454 Hospital. Patients were divided into 2 groups: i) the NPWT group (with vacuum-assisted closure, n=50); ii) the control group (with alginates dressings, n=50)...
October 2023: Saudi Medical Journal
https://read.qxmd.com/read/37756368/human-wound-and-its-burden-updated-2022-compendium-of-estimates
#23
EDITORIAL
Chandan K Sen
Significance: Chronic wounds affect 10.5 million (up 2.3 million from the 2014 update) of U.S. Medicare beneficiaries. Chronic wounds impact the quality of life of nearly 2.5% of the total population of the United States. This fraction is larger in the elderly. These wounds can lead to a range of complications and health care costs. Given the aging population, the continued threat of diabetes and obesity worldwide, and the persistent problem of infection, it is expected that chronic wounds will continue to be a substantial clinical, social, and economic challenge...
December 2023: Advances in Wound Care
https://read.qxmd.com/read/37728518/acellular-fish-skin-for-tissue-replacement
#24
JOURNAL ARTICLE
Callie Horn, Allegra Fierro, John C Lantis
In modern practice, xenografts play a crucial role in wound management due to their regenerative properties. Of the various xenografts currently available on the market, acellular fish skin (AFS) grafts have emerged as a more effective alternative to existing xenografts and other standard of care (SOC) treatments for wound healing. Since AFS grafts require minimal processing, they maintain their structural integrity and natural properties, including an abundance of Omega-3 fatty acids, which is a distinctive, pro-regenerative feature...
September 20, 2023: Surgical Technology International
https://read.qxmd.com/read/37711926/the-use-of-platelet-rich-plasma-in-the-treatment-of-diabetic-foot-ulcers-a-scoping-review
#25
REVIEW
Viktor Kunder, Kiran C Sharma, Zehra Rizvi, Ricardo Soubelet, Monika Ducharme
Platelet-rich plasma (PRP) has been recognized as a method of treatment in medicine since the 1980s. It primarily functions by releasing cytokines and growth factors that promote wound healing; these growth-promoting factors released by PRP enact new processes such as angiogenesis, collagen deposition, and tissue formation that can change wound-healing outcomes. Many studies recognize that PRP aids in chronic wound healing, which is advantageous for patients who suffer from chronic diabetic foot ulcers (DFUs)...
August 2023: Curēus
https://read.qxmd.com/read/37711741/skin-substitutes-as-treatment-for-chronic-wounds-current-and-future-directions
#26
REVIEW
Nicole M Vecin, Robert S Kirsner
Chronic wounds such as diabetic foot ulcers and venous leg ulcers place a significant burden on the healthcare system and in some cases, have 5-year mortality rates comparable to cancer. They negatively impact patients' quality of life due to pain, odor, decreased mobility, and social isolation. Skin substitutes are an advanced therapy recommended for wounds that fail to show decrease in size with standard care. The choice of substitute used should be based on evidence, which often differs based on wound etiology...
2023: Frontiers in Medicine
https://read.qxmd.com/read/37664469/sequential-treatment-for-diabetic-foot-ulcers-in-dialysis-patients-a-case-report
#27
Jin-Jun Wang, Yuan-Yuan Yu, Pin-Yi Wang, Xian-Ming Huang, Xiao Chen, Xi-Guang Chen
BACKGROUND: Diabetic foot ulcers (DFUs) are common in patients with diabetes, especially those undergoing hemodialysis. In severe cases, these ulcers can cause damage to the lower extremities and lead to amputation. Traditional treatments such as flap transposition and transfemoral amputation are not always applicable in all cases. Therefore, there is a need for alternative treatment methods. CASE SUMMARY: This report describes a 62-year-old female patient who was admitted to the hospital with plantar and heel ulcers on her left foot...
August 15, 2023: World Journal of Diabetes
https://read.qxmd.com/read/37662508/a-novel-wound-therapy-modality-autologous-wound-edge-dotted-full-thickness-skin-grafting-improving-diabetic-foot-ulcer-healing
#28
JOURNAL ARTICLE
Jianhao Huang, Jingxia Sun, Qiu Wang, Jianming Mo, Yuechou Nong, Zhenwei Zhai, Xiuxian Huang, Jiacheng Mo, Wensheng Lu
AIM: To explore the therapeutic efficacy of autologous wound edge-dotted full-thickness skin grafting in improving diabetic foot ulcer healing. METHODS: Sixty-three patients were divided into three groups: conventional wound therapy (CWT) (n = 23), platelet-rich plasma (PRP) (n = 20), and graft (n = 20). All participants were followed up for 12 weeks. The therapeutic efficacy of the three different wound treatment modalities was analyzed. RESULTS: After follow-up, 37 (58...
2023: International Journal of General Medicine
https://read.qxmd.com/read/37619700/to-mesh-or-not-to-mesh-what-is-the-ideal-meshing-ratio-for-split-thickness-skin-grafting-of-the-lower-extremity
#29
JOURNAL ARTICLE
Stephanie E Shin, Daisy Spoer, Garrett Franzoni, Lauren Berger, Alison Hill, Adaah A Sayyed, Niki Noe, John S Steinberg, Christopher E Attinger, Karen K Evans
Split-thickness skin grafts can provide effective autologous wound closure in patients with dysvascular comorbidities. Meshing the graft allows for reduced donor site morbidity and expanded coverage. This study directly compares outcomes across varying meshing ratios used to treat chronic lower extremity wounds. Patients who received split-thickness skin grafts to their lower extremity for chronic ulcers from December 2014 to December 2019 at a single center were retrospectively reviewed. Patients were stratified by meshing ratios: nonmeshed (including pie crusting), 1...
August 22, 2023: Journal of Foot and Ankle Surgery
https://read.qxmd.com/read/37593695/hybrid-regenerative-therapy-for-successful-reconstruction-of-an-infected-traumatized-diabetic-foot-wound
#30
JOURNAL ARTICLE
Srinjoy Saha
Diabetic foot ulcers are a significant complication of diabetes, affecting millions globally, and require appropriate antibiotics, surgical debridement, wound care, and metabolic optimization for management. This article presents an innovative hybrid regenerative therapy for reconstructing an infected, traumatized foot wound of a 62-year-old man with diabetes mellitus who presented with a week-old injury after a car accident. At presentation, he had a 14 × 10 cm dorsal foot wound with skin necrosis, pus discharge, and bony instability owing to partial fractures and joint dislocations...
August 2023: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/37459652/novel-mediators-regulating-angiogenesis-in-diabetic-foot-ulcer-healing
#31
JOURNAL ARTICLE
Vikrant Rai, Hoangvi Le, Devendra K Agrawal
A non-healing diabetic foot ulcer (DFU) is a debilitating clinical problem amounting to socioeconomic and psychosocial burdens. DFUs increase morbidity due to prolonged treatment and mortality in the case of non-treatable ulcers resulting in gangrene and septicemia. The overall amputation rate of the lower extremity with DFU ranges from 3.34% to 42.83%. Wound debridement, antibiotics, applying growth factors, negative pressure wound therapy, hyperbaric oxygen therapy, topical oxygen, and skin grafts are common therapies for DFU...
October 1, 2023: Canadian Journal of Physiology and Pharmacology
https://read.qxmd.com/read/37399591/fibular-strut-graft-for-primary-ankle-arthrodesis-in-diabetic-charcot-neuroarthropathy-patients
#32
Andre Triadi Desnantyo, Muhammad Hanun Mahyuddin, Pandit Bagus Tri Saputra, Olga Putri Atsira
INTRODUCTION: Arthrodesis is an expensive procedure that is less applicable in developing countries. In this case report we reported a case of diabetic charcot neuroartropathy (CN) with primary ankle arthrodesis technique with a fibular strut graft which is considered cheaper and has a higher union rate. CASE DESCRIPTION: A 47 years old female with complaints of pain in her right ankle after falling down the stairs with foot inverted one month before admission...
July 2023: International Journal of Surgery Case Reports
https://read.qxmd.com/read/37399481/arterialized-vein-bypass-graft-recipient-vessel-in-free-tissue-transfer-covering-diabetic-foot-ulcers-complicated-by-critical-limb-ischemia
#33
JOURNAL ARTICLE
Ryu Tran, Zoė K Haffner, Robert P Slamin, Cameron M Akbari, Karen K Evans
Limb salvage options are limited in diabetic patients with critical limb ischemia. Soft tissue coverage remains technically demanding with limited recipient vessels for free tissue transfer. These factors make revascularization alone challenging. When open bypass revascularization is possible, venous bypass graft is optimal and functions as a recipient vessel for staged free tissue transfer.The authors present 2 cases using a combination approach of staged venous bypass graft revascularization followed by free tissue transfer with anastomosis to the venous bypass graft resulting in successful limb preservation...
June 1, 2023: Annals of Plastic Surgery
https://read.qxmd.com/read/37395488/advanced-biomaterials-and-topical-medications-for-treating-diabetic-foot-ulcers-a-systematic-review-and-network-meta-analysis
#34
JOURNAL ARTICLE
Angela Chien-Yu Chen, Yi Lu, Chi-Ying Hsieh, Yo-Shen Chen, Ke-Chung Chang, Dun-Hao Chang
Significance: With the increasing diabetic population worldwide, diabetic foot ulcers (DFUs) are a significant concern. This study aimed to compare the efficacy of skin substitutes, biomaterials, and topical agents with standard care. Recent Advances: A meta-analysis was conducted using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, EMBASE, and Web of Science were searched using the following keywords: diabetes mellitus AND skin graft OR tissue replacement OR dressing OR drug...
February 2024: Advances in Wound Care
https://read.qxmd.com/read/37376103/polymers-and-bioactive-compounds-with-a-macrophage-modulation-effect-for-the-rational-design-of-hydrogels-for-skin-regeneration
#35
JOURNAL ARTICLE
Mirna L Sánchez, Hugo Valdez, Micaela Conde, Pamela Viaña-Mendieta, Aldo R Boccaccini
The development of biomaterial platforms for dispensing reagents of interest such as antioxidants, growth factors or antibiotics based on functional hydrogels represents a biotechnological solution for many challenges that the biomedicine field is facing. In this context, in situ dosing of therapeutic components for dermatological injuries such as diabetic foot ulcers is a relatively novel strategy to improve the wound healing process. Hydrogels have shown more comfort for the treatment of wounds due to their smooth surface and moisture, as well as their structural affinity with tissues in comparison to hyperbaric oxygen therapy, ultrasound, and electromagnetic therapies, negative pressure wound therapy or skin grafts...
June 5, 2023: Pharmaceutics
https://read.qxmd.com/read/37327393/two-pronged-microbe-delivery-of-nitric-oxide-and-oxygen-for-diabetic-wound-healing
#36
JOURNAL ARTICLE
Huan-Huan Chen, Fang-Sheng Fu, Qi-Wen Chen, Yun Zhang, Xian-Zheng Zhang
Chronic inflammation and hypoxia in the microenvironment of diabetic foot ulcers (DFUs) can result in sustained vascular impairment, hindering tissue regeneration. While both nitric oxide and oxygen have been shown to promote wound healing in DFUs through anti-inflammatory and neovascularization, there is currently no available therapy that delivers both. We present a novel hydrogel consisting of Weissella and Chlorella , which alternates between nitric oxide and oxygen production to reduce chronic inflammation and hypoxia...
June 16, 2023: Nano Letters
https://read.qxmd.com/read/37170536/role-of-adipose-derived-stem-cells-in-patients-with-diabetic-foot-ulcers-systematic-review-and-meta-analysis-of-randomised-controlled-trials
#37
REVIEW
Mohamed Elsharkawi, Baker Ghoneim, Miriam O'Sullivan, Aoife J Lowery, Daniel Westby, Wael Tawfick, Stewart R Walsh
Few studies to date have investigated the role of adipose derived stem cells (ADSCs) in patients with diabetic foot ulcers (DFU). We aimed to conduct a systematic search of the literature to explore the available evidence behind ADSCs application in patients with DFU to establish if it has any added benefit regarding healing rate and healing time in this cohort of patients. The PubMed and Embase databases were searched for eligible studies. Only randomised controlled trials which investigated the impact of ADSCs alone on the healing of DFU were considered eligible and were included for the review...
May 11, 2023: International Journal of Lower Extremity Wounds
https://read.qxmd.com/read/37146110/single-use-negative-pressure-wound-therapy-applied-on-various-wound-types-an-interventional-case-series
#38
JOURNAL ARTICLE
Neha Amin, Bounthavy Homsombath, John Rumbaugh, Beretta Craft-Coffman, Shawn P Fagan, Tayseer Chowdhry, Joan Wilson, Rey Paglinawan, Karin Lussi, Zaheed Hassan
PURPOSE: The purpose of this study was to determine whether a single-use negative pressure wound therapy (NPWT) system achieves individualized goals of therapy when used to treat patients with a variety of wound types. DESIGN: Multiple case series. SUBJECTS AND SETTING: The same comprised 25 participants; their mean age was 51.2 years (SD: 18.2; range: 19-79 years); 14 were male (56%) and 11 were female (44%). Seven study participants withdrew from study participation...
May 2023: Journal of Wound, Ostomy, and Continence Nursing
https://read.qxmd.com/read/37082504/fish-skin-grafts-versus-alternative-wound-dressings-in-wound-care-a-systematic-review-of-the-literature
#39
REVIEW
Mohamed Ibrahim, Haneen S Ayyoubi, Layth A Alkhairi, Hozaifa Tabbaa, Isaac Elkins, Ravish Narvel
Wound healing poses a variety of challenges making it a vital subject in medicine. With the advancement of science, we have seen the use of a new xenograft known as acellular fish skin (AFS) grafts that are derived from either Atlantic cod or Nile Tilapia. Fish skin has shown anti-inflammatory and anti-bacterial properties that support and improve wound healing in a variety of wounds including burns and diabetic foot ulcers (DFU). There is ongoing research that evaluates the efficacy of fish skin grafts in comparison to alternative wound healing techniques...
March 2023: Curēus
https://read.qxmd.com/read/37023475/final-efficacy-and-cost-analysis-of-a-fish-skin-graft-vs-standard-of-care-in-the-management-of-chronic-diabetic-foot-ulcers-a-prospective-multicenter-randomized-controlled-clinical-trial
#40
RANDOMIZED CONTROLLED TRIAL
John C Lantis Ii, Eric J Lullove, Brock Liden, Patrick McEneaney, Allen Raphael, Robert Klein, Christopher Winters, Ruby N Huynh
INTRODUCTION: DFUs remain a cause of significant morbidity. OBJECTIVE: This is the third of 3 planned articles reporting on a prospective, multicenter, randomized controlled trial evaluating the use of omega-3-rich acellular FSG compared with CAT in the management of DFUs. MATERIALS AND METHODS: A total of 102 patients with a DFU (n = 51 FSG, n = 51 CAT) participated in the trial as ITT candidates, with 77 of those patients included in the PP analysis (n = 43 FSG, n = 34 CAT)...
April 2023: Wounds: a Compendium of Clinical Research and Practice
keyword
keyword
86219
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.